43 related articles for article (PubMed ID: 23296398)
1. Substituent effects on Gd(III)-based MRI contrast agents: optimizing the stability and selectivity of the complex and the number of coordinated water molecules.
Pierre VC; Botta M; Aime S; Raymond KN
Inorg Chem; 2006 Oct; 45(20):8355-64. PubMed ID: 16999435
[TBL] [Abstract][Full Text] [Related]
2. Optimized relaxivity and stability of [Gd(H(2,2)-1,2-HOPO)(H2O)]- for use as an MRI contrast agent.
Jocher CJ; Botta M; Avedano S; Moore EG; Xu J; Aime S; Raymond KN
Inorg Chem; 2007 Jun; 46(12):4796-8. PubMed ID: 17497773
[TBL] [Abstract][Full Text] [Related]
3. Lanthanide DO3A-Complexes Bearing Peptide Substrates: The Effect of Peptidic Side Chains on Metal Coordination and Relaxivity.
Laine S; Morfin JF; Galibert M; Aucagne V; Bonnet CS; Tóth É
Molecules; 2021 Apr; 26(8):. PubMed ID: 33918899
[TBL] [Abstract][Full Text] [Related]
4. [Gd(CyPic3A)(H2O)2]-: a stable, bis(aquated) and high-relaxivity Gd(III) complex.
Gale EM; Kenton N; Caravan P
Chem Commun (Camb); 2013 Sep; 49(73):8060-2. PubMed ID: 23903523
[TBL] [Abstract][Full Text] [Related]
5. Development of Ln(III) Derivatives as
Kaster MA; Caldwell MA; Meade TJ
Inorg Chem; 2024 May; 63(21):9877-9887. PubMed ID: 38748735
[No Abstract] [Full Text] [Related]
6. Impact of the lanthanide contraction on the activity of a lanthanide-dependent methanol dehydrogenase - a kinetic and DFT study.
Lumpe H; Pol A; Op den Camp HJM; Daumann LJ
Dalton Trans; 2018 Aug; 47(31):10463-10472. PubMed ID: 30020281
[TBL] [Abstract][Full Text] [Related]
7. Multiplexed Probing of Proteolytic Enzymes Using Mass Cytometry-Compatible Activity-Based Probes.
Poreba M; Groborz KM; Rut W; Pore M; Snipas SJ; Vizovisek M; Turk B; Kuhn P; Drag M; Salvesen GS
J Am Chem Soc; 2020 Sep; 142(39):16704-16715. PubMed ID: 32870676
[TBL] [Abstract][Full Text] [Related]
8. Lanthanide probes for bioresponsive imaging.
Heffern MC; Matosziuk LM; Meade TJ
Chem Rev; 2014 Apr; 114(8):4496-539. PubMed ID: 24328202
[No Abstract] [Full Text] [Related]
9. Gadolinium(III) complexes as MRI contrast agents: ligand design and properties of the complexes.
Hermann P; Kotek J; Kubícek V; Lukes I
Dalton Trans; 2008 Jun; (23):3027-47. PubMed ID: 18521444
[TBL] [Abstract][Full Text] [Related]
10. Gd-hydroxypyridinone (HOPO)-based high-relaxivity magnetic resonance imaging (MRI) contrast agents.
Datta A; Raymond KN
Acc Chem Res; 2009 Jul; 42(7):938-47. PubMed ID: 19505089
[TBL] [Abstract][Full Text] [Related]
11. New tris-3,4-HOPO lanthanide complexes as potential imaging probes: complex stability and magnetic properties.
Mendonça AC; Martins AF; Melchior A; Marques SM; Chaves S; Villette S; Petoud S; Zanonato PL; Tolazzi M; Bonnet CS; Tóth É; Di Bernardo P; Geraldes CF; Santos MA
Dalton Trans; 2013 May; 42(17):6046-57. PubMed ID: 23296398
[TBL] [Abstract][Full Text] [Related]
12. Isoquinoline-based lanthanide complexes: bright NIR optical probes and efficient MRI agents.
Caillé F; Bonnet CS; Buron F; Villette S; Helm L; Petoud S; Suzenet F; Tóth E
Inorg Chem; 2012 Feb; 51(4):2522-32. PubMed ID: 22233349
[TBL] [Abstract][Full Text] [Related]
13. In vitro studies of lanthanide complexes for the treatment of osteoporosis.
Mawani Y; Cawthray JF; Chang S; Sachs-Barrable K; Weekes DM; Wasan KM; Orvig C
Dalton Trans; 2013 May; 42(17):5999-6011. PubMed ID: 23299719
[TBL] [Abstract][Full Text] [Related]
14. The effect of ligand scaffold size on the stability of tripodal hydroxypyridonate gadolinium complexes.
O'Sullivan B; Doble DM; Thompson MK; Siering C; Xu J; Botta M; Aime S; Raymond KN
Inorg Chem; 2003 Apr; 42(8):2577-83. PubMed ID: 12691564
[TBL] [Abstract][Full Text] [Related]
15. Lanthanide chelates of (bis)-hydroxymethyl-substituted DTTA with potential application as contrast agents in magnetic resonance imaging.
Silvério S; Torres S; Martins AF; Martins JA; André JP; Helm L; Prata MI; Santos AC; Geraldes CF
Dalton Trans; 2009 Jun; (24):4656-70. PubMed ID: 19513474
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
